THE RECENT PHASE 3 STUDY IS MUCH SMALLER COMPARED TO THE PREVIOUS BIG SUCCESS PHASE 2 STUDY.
THE CURRENT MARKET CAP OF 125 MILLION$ IS RIDICULOUS FOR A BIG BLOCKBUSTER CANDIDATE LIKE UROCIDIN .
Urocidin (Bladder Cancer) Phase 3 is a small Studie with 105 Patients ,only "20% complete response” required for Phase 3 success .
UROCIDIN REACHES 70% COMPLETE RESPONSE IN 128 PATIENTS .THATS DEFINITELY A BIG BLOCKBUSTER ,DENDREON ONLY REACHES 23% CR WITH PROVENGE AND NOW THEY HAVE A MARKET CAP OF 5 BILLION$ .
BLOCKBUSTER PHASE II RESULTS :
ThisDNA is quite unique in that the tumorcells, even when they try to mutatearound it, are unable to induceresistance to this compound; andit'sextremely safe. Wehave a 70%complete response rate in patients whofailed other therapies,so ourPhase II data, which is in the publicdomain, shows about 128patientswith an average complete response ofabout 70%.These are patients whoat the end of the study weredisease-free and hadreally no side effectsworth noting due to theproduct. The patients wereable to maintaintreatment, whereas withoutthe treatments they drop outbecause of sideeffects, so that is ourprimary technology. It has beenshown effective in-vitro in the lab against many different types ofcancer. In fact, wecan't find a cancer cell it doesn't kill.
ENDOKNOWS THEY HAVE A MEGA BLOCKBUSTER IN THEIR HANDS ,THATS WHY THEYKEEPIT SECRET .I THINK BIONICHE IS ENDO`S NEXT BUYOUT CANDIDATE .
LOOK AT BIONICHE´S SHARE PRICE THE STOCK IS UP 400% IN ONE YEAR AND CONTINUES TO CLIMB HIGHER . WHAT DOES THAT TELLS YOU ???
DO YOU REMEMBER :
Dendreon went from 1.60 to 54.06 with 143 million shares outstanding. No splits, no dilutive offerings in that time period.
BIONICHE HAS 72 MILLION SHARES OUT AND NO SPLITS ,NO DILUTION ,NO INSIDER SELLING EVEN AFTER 400% PRICE INCREASE .
WE SIT ON A GOLDMINE ..YOU WILL SEE THAT VERY SOON .
>>THE CURRENT MARKET CAP OF 125 MILLION$ IS RIDICULOUS FOR A BIG BLOCKBUSTER CANDIDATE LIKE UROCIDIN .
Given the round of financing, the market is valuing the stock @ about a buck fifty at the moment. Seems about right given the risk/reward data that is out there now.
These guys (link below) are smarter and more informed that me/you. Follow their lead and you/we have a shot at making some $$ on this stock. No such thing as a free lunch tho. This stock can easily dump back to pennies on (real) bad news.
An excellent question sammy, pumpers on this site can't deal with the fact that a stock ebbs and flows. They'd fine watching their flock, and I don't use that word carelessly, lose .20 (which they've just done for those that held on believing their bullfeathers) rather than say we're done for now, come back before the next news for another run-up. It's a stock, not a girlfriend! Trade 'em like ya hate 'em!
Yes it could happen any day now .....
Upcoming Milestones 2010
2009/2010 Conditional license for E. coli cattle vaccine in the U.S.
2009/2010 Achievement of pre-commercialization milestone payments for
2010 First U.S. sales of E. coli cattle vaccine
2010 Results of refractory Phase III bladder cancer